دورية أكاديمية
67 (PB057) - Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors
| العنوان: | 67 (PB057) - Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors |
|---|---|
| المؤلفون: | Dziadziuszko, R., Garralda Cabanas, E., Rojas, K., Chelstowska, M., Blaszkowska, M., Dudziak, R., Rzymski, T., Angelosanto, N., Littlewood, P., Nogai, H., Boni, V., Lugowska, I. |
| المصدر: | In European Journal of Cancer October 2022 174 Supplement 1:S23-S23 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 09598049 |
|---|---|
| DOI: | 10.1016/S0959-8049(22)00865-6 |